FDA Approved: VELSIPITY — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for VELSIPITY (etrasimod) to update the product label, including changes to indications, dosing, or safety information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• VELSIPITY (ETRASIMOD)

Snippet

SUPPL AP for VELSIPITY (ETRASIMOD)